297 related articles for article (PubMed ID: 24955077)
1. Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort.
Szugye HS; Zeft AS; Spalding SJ
Pediatr Rheumatol Online J; 2014; 12():21. PubMed ID: 24955077
[TBL] [Abstract][Full Text] [Related]
2. Early diagnosis of pediatric Takayasu arteritis (TA) not fullfiling the ACR criteria.
Bracaglia C; Buonuomo PS; Campana A; Insalaco A; Nicolai R; Cortis E
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S140. PubMed ID: 19646360
[No Abstract] [Full Text] [Related]
3. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C
Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709
[TBL] [Abstract][Full Text] [Related]
4. Demographic, Clinical, and Radiologic Characteristics of a Cohort of Patients with Takayasu Arteritis.
Sanchez-Alvarez C; Mertz LE; Thomas CS; Cochuyt JJ; Abril A
Am J Med; 2019 May; 132(5):647-651. PubMed ID: 30615861
[TBL] [Abstract][Full Text] [Related]
5. Childhood Takayasu arteritis: disease course and response to therapy.
Aeschlimann FA; Eng SWM; Sheikh S; Laxer RM; Hebert D; Noone D; Twilt M; Pagnoux C; Benseler SM; Yeung RSM
Arthritis Res Ther; 2017 Nov; 19(1):255. PubMed ID: 29166923
[TBL] [Abstract][Full Text] [Related]
6. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
[TBL] [Abstract][Full Text] [Related]
7. Infantile Takayasu: clinical features and long-term outcome.
Miller-Barmak A; Sztajnbok F; Balik Z; Borzutzky A; Fogel LA; Goldzweig O; Ozen S; Butbul Aviel Y
Rheumatology (Oxford); 2023 Sep; 62(9):3126-3132. PubMed ID: 36495199
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and classification criteria of Takayasu arteritis.
de Souza AW; de Carvalho JF
J Autoimmun; 2014; 48-49():79-83. PubMed ID: 24461381
[TBL] [Abstract][Full Text] [Related]
9. Infliximab in Takayasu arteritis: a safe alternative?
Karageorgaki ZT; Mavragani CP; Papathanasiou MA; Skopouli FN
Clin Rheumatol; 2007 Jun; 26(6):984-7. PubMed ID: 16633710
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal study of 16 patients with Takayasu's arteritis: clinical features and therapeutic management.
Petrovic-Rackov L; Pejnovic N; Jevtic M; Damjanov N
Clin Rheumatol; 2009 Feb; 28(2):179-85. PubMed ID: 18797980
[TBL] [Abstract][Full Text] [Related]
11. Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques.
Freitas DS; Camargo CZ; Mariz HA; Arraes AE; de Souza AW
Rheumatol Int; 2012 Mar; 32(3):703-9. PubMed ID: 21152919
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
13. Takayasu arteritis in children.
Cakar N; Yalcinkaya F; Duzova A; Caliskan S; Sirin A; Oner A; Baskin E; Bek K; Soylu A; Fitoz S; Bayazit AK; Bircan Z; Ozen S; Uncu N; Ekim M
J Rheumatol; 2008 May; 35(5):913-9. PubMed ID: 18381778
[TBL] [Abstract][Full Text] [Related]
14. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis.
Jolly M; Curran JJ
J Clin Rheumatol; 2005 Aug; 11(4):213-5. PubMed ID: 16357759
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study.
Stern S; Clemente G; Reiff A; Ramos MP; Marzan KA; Terreri MT
J Clin Rheumatol; 2014 Jun; 20(4):183-8. PubMed ID: 24847743
[TBL] [Abstract][Full Text] [Related]
16. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom.
Eleftheriou D; Varnier G; Dolezalova P; McMahon AM; Al-Obaidi M; Brogan PA
Arthritis Res Ther; 2015 Feb; 17(1):36. PubMed ID: 25879697
[TBL] [Abstract][Full Text] [Related]
17. Clinical study of children with Takayasu arteritis: a retrospective study from a single center in China.
Feng Y; Tang X; Liu M; Zhou J; Zhao X; Li Q
Pediatr Rheumatol Online J; 2017 Apr; 15(1):29. PubMed ID: 28416004
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
[TBL] [Abstract][Full Text] [Related]
19. [Takayasu's arteritis--case report and review of the literature].
Schurch MA; Gerster JC
Rev Med Suisse Romande; 2000 Oct; 120(10):777-80. PubMed ID: 11109906
[TBL] [Abstract][Full Text] [Related]
20. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
Villiger PM
Internist (Berl); 2019 Oct; 60(10):1059-1073. PubMed ID: 31471629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
